JW Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-8,500
Closed -$7.7M 16
2024
Q2
$7.7M Sell
8,500
-5,000
-37% -$4M 3.17% 7
2024
Q1
$10.5M Sell
13,500
-13,500
-50% -$9.61M 3.84% 4
2023
Q4
$15.7M Hold
27,000
8.98% 3
2023
Q3
$14.5M Hold
27,000
6.28% 3
2023
Q2
$12.7M Hold
27,000
4.61% 3
2023
Q1
$9.27M Buy
+27,000
New +$9.11M 3.56% 4

Other funds holding LLY

JW Asset Management's LLY Position: Q3 2024 in Review

JW Asset Management sold out of Eli Lilly (LLY) in Q3 2024, closing a stake of 8,500 shares — an estimated $7.7M sold.

JW Asset Management first reported a position in LLY in Q1 2023 and held it in 6 quarters. The position peaked at $15.7M in Q4 2023. 3,657 funds tracked by Wall St. Rank hold LLY as of Q3 2024.

  • JW Asset Management reported no remaining Eli Lilly position as of Q3 2024 after selling out during the quarter.
  • JW Asset Management sold 8,500 Eli Lilly shares in Q3 2024, an estimated $7.7M.
  • JW Asset Management first reported a position in Eli Lilly in Q1 2023 and held it in 6 quarters.
  • JW Asset Management's Eli Lilly position peaked at $15.7M in Q4 2023.
  • 3,657 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2024.

Based on JW Asset Management's 13F filing for Q3 2024, filed 8 Nov 2024.